TWIM
NVO

TIAA Wealth Investment Management’s Novo Nordisk NVO Stock Holding History

TIAA Wealth Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Sell
22,279
-326,839
-94% -$14M 0.01% 185
2026
Q1 		$12.8M Buy
+349,118
New +$16.5M 0.1% 97

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

TIAA Wealth Investment Management's NVO Position: Q2 2026 in Review

TIAA Wealth Investment Management reduced its Novo Nordisk (NVO) stake by 94% in Q2 2026, selling an estimated $14M and leaving 22,279 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #185.

TIAA Wealth Investment Management first reported a position in NVO in Q1 2026 and has held it in 2 quarters since. The position peaked at $12.8M in Q1 2026. 1,293 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • TIAA Wealth Investment Management held 22,279 shares of Novo Nordisk worth $1.07M as of Q2 2026.
  • TIAA Wealth Investment Management sold 326,839 Novo Nordisk shares in Q2 2026, an estimated $14M.
  • Novo Nordisk made up 0.01% of TIAA Wealth Investment Management's portfolio in Q2 2026, its #185 holding.
  • TIAA Wealth Investment Management first reported a position in Novo Nordisk in Q1 2026 and has held it in 2 quarters since.
  • TIAA Wealth Investment Management's Novo Nordisk position peaked at $12.8M in Q1 2026.
  • 1,293 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on TIAA Wealth Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.